Innovex International

INVXNYSEUSD

THESIS ALERT

Email me when the INVX thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$25.25
+$0.34 (+1.36%)Today 1M −11.23%
After hours$25.250.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$24.91
Prior regular-session close from the quote source.
$24.96–$25.61
Regular-session low and high so far today.
336.3K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 22 projected
Projected for 2027-02-22 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$19.91–$33.71
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own INVX if management proves M&A is accretive, margins recover and EPS dilution is reversed.

INVX price history

Latest price$25.25Today+$0.34 (+1.36%)
INVX -11.03%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Successful integration of recent M&A (Merger, DWS, Citadel, SCF) will convert acquisition-driven scale and new products into sustained revenue growth beyond one-time transaction lifts.HoldingMateriality: High

    Revenue increased from 660803000 (2024) to 978251000 (2025). If integration drives cross‑sell, channel expansion and customer retention, revenue growth will be durable and justify the multiple; if integration fails, revenue will revert and goodwill/dilution will impair returns.

    Watch: Integration delays, material warranty or quality issues from acquired product lines that cause customer churn or returns.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenue increased from 660803000 (2024) to 978251000 (2025).

    Open source ↗
  • Because Innovex's products are mission‑critical consumables that materially improve well economics, the company can sustain above-commodity gross margins and aftermarket attachment that protect pricing and margin power.StrengtheningMateriality: High

    Gross_profit rose from 195437000 (2023) to 232631000 (2024) to 303280000 (2025). Sustained gross margins secure operating profitability and cash flow even through cyclical oil & gas spending swings; losing this pricing power converts revenue volatility directly into margin erosion.

    Watch: Commoditization or aggressive underpricing by local low‑cost competitors or distributors in key regions.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Gross_profit rose from 195437000 (2023) to 232631000 (2024) to 303280000 (2025).

    Open source ↗
  • The SCF low‑cost country manufacturing initiative and other supply‑chain actions will lower production costs and lift operating income and cash generation over time.HoldingMateriality: Medium

    Operating_income increased from 49075000 (2024) to 132625000 (2025). Cost reductions translate directly into higher operating income and free cash flow, enabling EPS recovery or return of capital; failure keeps margins pressured despite revenue growth.

    Watch: SCF fails to achieve expected yield/quality or encounters logistics/tariff/geopolitical disruption.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating_income increased from 49075000 (2024) to 132625000 (2025).

    Open source ↗
  • EPS will remain pressured unless future organic margin expansion or cash returns (buybacks/dividends) materially offset the share issuance used to fund the Merger and acquisitions.StrengtheningMateriality: Medium

    eps_diluted fell from 2.77 (2024) to 1.2 (2025). Per‑share returns determine shareholder outcomes; persistent dilution without accretion destroys value even if absolute profit rises.

    Watch: Management executes accretive M&A, generates higher free cash flow and announces share repurchases.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    eps_diluted fell from 2.77 (2024) to 1.2 (2025).

    Open source ↗
  • Top-line and cash generation are cyclical and will track upstream drilling activity and operator capex; a sustained decline in drilling intensity will materially reduce revenue and cashflow.HoldingMateriality: Medium

    Operating_cash_flow moved from 75864000 (2023) to 93439000 (2024) to 190912000 (2025) alongside revenue increases. If upstream capex retrenches, mission‑critical demand falls and the business cannot fully offset lost volume with pricing or new product penetration.

    Watch: A prolonged oil-price downturn or major customers materially cutting drilling programs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating_cash_flow moved from 75864000 (2023) to 93439000 (2024) to 190912000 (2025) alongside revenue increases.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Successful integration of recent M&A (Merger, DWS, Citadel, SCF) will convert acquisition-driven scale and new products into sustained revenue growth beyond one-time transaction lifts. If integration drives cross‑sell, channel expansion and customer retention, revenue growth will be durable and justify the multiple; if integration fails, revenue will revert and goodwill/dilution will impair returns.

Because Innovex's products are mission‑critical consumables that materially improve well economics, the company can sustain above-commodity gross margins and aftermarket attachment that protect pricing and margin power. Sustained gross margins secure operating profitability and cash flow even through cyclical oil & gas spending swings; losing this pricing power converts revenue volatility directly into margin erosion.

The SCF low‑cost country manufacturing initiative and other supply‑chain actions will lower production costs and lift operating income and cash generation over time. Cost reductions translate directly into higher operating income and free cash flow, enabling EPS recovery or return of capital; failure keeps margins pressured despite revenue growth.

EPS will remain pressured unless future organic margin expansion or cash returns (buybacks/dividends) materially offset the share issuance used to fund the Merger and acquisitions. Per‑share returns determine shareholder outcomes; persistent dilution without accretion destroys value even if absolute profit rises.

Top-line and cash generation are cyclical and will track upstream drilling activity and operator capex; a sustained decline in drilling intensity will materially reduce revenue and cashflow. If upstream capex retrenches, mission‑critical demand falls and the business cannot fully offset lost volume with pricing or new product penetration.

All standing thesis claims
Original report summary

management proves M&A is accretive, margins recover and EPS dilution is reversed.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Innovex International

Where the evidence on Innovex International stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 2 strengthening and 3 holding.

Bull case: what the evidence supports

  • Successful integration of recent M&A (Merger, DWS, Citadel, SCF) will convert acquisition-driven scale and new products into sustained revenue growth beyond one-time transaction lifts.

    sec.gov ↗

  • Because Innovex's products are mission‑critical consumables that materially improve well economics, the company can sustain above-commodity gross margins and aftermarket attachment that protect pricing and margin power.

    sec.gov ↗

  • The SCF low‑cost country manufacturing initiative and other supply‑chain actions will lower production costs and lift operating income and cash generation over time.

    sec.gov ↗

  • EPS will remain pressured unless future organic margin expansion or cash returns (buybacks/dividends) materially offset the share issuance used to fund the Merger and acquisitions.

    sec.gov ↗

  • Top-line and cash generation are cyclical and will track upstream drilling activity and operator capex; a sustained decline in drilling intensity will materially reduce revenue and cashflow.

    sec.gov ↗

Bear case: what would count against it

  • Integration delays, material warranty or quality issues from acquired product lines that cause customer churn or returns.

    sec.gov ↗

  • Commoditization or aggressive underpricing by local low‑cost competitors or distributors in key regions.

    sec.gov ↗

  • SCF fails to achieve expected yield/quality or encounters logistics/tariff/geopolitical disruption.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Innovex International

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed Innovex International’s thesis. Its break conditions are checked against every new filing as it lands.

Early warning

The break condition read on the trailing twelve months through Innovex International’s latest quarterly report, ahead of the annual figure it is written on.

  • Operating-margin compression, trailing 12 months

    Across all companies, this kind of early warning has happened 2,641 times before. Those stocks trailed the market by a median of 1% over the next six months, and 36% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Innovex International filed an SEC 8-K on 2026-10-29: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Entered a material definitive agreement.

    Innovex International filed an SEC 8-K on 2026-08-10: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Innovex International filed an SEC 8-K on 2026-08-03: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Integration delays, material warranty or quality issues from acquired product lines that cause customer churn or returns.
  • Commoditization or aggressive underpricing by local low‑cost competitors or distributors in key regions.
  • SCF fails to achieve expected yield/quality or encounters logistics/tariff/geopolitical disruption.
  • Management executes accretive M&A, generates higher free cash flow and announces share repurchases.
  • A prolonged oil-price downturn or major customers materially cutting drilling programs.

INVX news

Loading headlines…

Financial statements

INVX income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

INVX: quick answers

When does Innovex International (INVX) report earnings next?
Innovex International's next results are projected for February 22, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 29, 2026. Earnings calendar
What is INVX's short interest?
As of October 30, 2026, 3.3M INVX shares were sold short, 4.73% of its shares outstanding, up 11.0% from the count before. At the stock's average daily volume that is 5.1 days to cover. FINRA publishes the count twice a month. INVX short interest history
Have members of Congress traded INVX?
2 trades in INVX have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed INVX trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.